Precursor B lymphoblastic leukaemia / lymphoma, ALL

A neoplasm of lymphoblasts committed to B-cell lineage. Most cases involve blood and bone marrow (B lymphoblastic leukaemia, B-ALL), a few present with primary nodal or extanodal tissue deposits (B lymphoblastic lymphoma, B-LBL).

Epidemiology

B-ALL is predominantly a disease of childhood (75% of cases <6 years old). B lymphoblastic lymphoma constitutes ~10% of cases of lymphoblastic lymphoma and 75% of cases are less than 18 years old.

Clinical features

B-ALL usually presents with bone marrow failure (thrombocytopenia/anaemia/neutropenia). The leukocyte count may be low, normal or raised. B-ALL also involves the CNS, lymph nodes, spleen, liver and gonads. B-LBL commonly involves skin (often as multiple nodules) , bone, soft tissues and lymph nodes.

Histopathology

Small to medium-sized blast cells with scantly cytoplasm. Nucleoli are inconspicuous.

Immunohistochemistry 80%-90% of cases show an immature B cell immunophenotype:

 

immunoreactivity

notes

TdT

+

nuclear positivity is unique to LBL

CD10

most cases, except for t(4;11)(q21;q23 ) ALL which is usually negative

 

CD13

may be positive

 

CD19

almost always

 

CD20

variable

 

CD22

variable

cytoplasmic staining is considered lineage-specific

CD24

most cases, except for t(4;11)(q21;q23 ) ALL which is frequently negative

 

CD33

may be positive

 

CD45

variable

 

CD79a

almost always

 

HLA-DR

+

 

Surface Ig

rarely positive

 

myeloperoxidase

-

 

cytoplasmic m heavy chain

+

 

 

†: fresh frozen tissue only

Differential diagnosis

References

World Health Organization Classification of Tumours, Tumours of the haematopoietic and lymphoid tissues, IARC Press 2001.

 

 

This page last revised 16.12.2002.

©SMUHT/PW Bishop